怪物饮料 MNST 深 沪
等待开盘 04-02 09:30:00 美东时间
73.04
+0.580
+0.80%
华盛通- 最 高73.20
- 今 开72.42
- 成交量 151.99万股
- 最 低 71.865
- 昨 收 72.46
- 总市值 714.26亿
- 52周最高 87.38
- 市盈率 静 37.74
- 换手率 0.16%
- 52周最低 57.005
- 委 比 -72.44%
- 总股本 9.78亿
- 历史最高 87.38
- 量 比 0.53
- 振 幅 1.84%
- 历史最低 5.7383
- 每 手 1
- 风险率 7.81%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅172.14%！Alumis获Oppenheimer上调目标价至55美元；摩根大通首予希捷科技"超配"评级，目标价525美元
今日重点评级关注：Oppenheimer：维持Alumis"跑赢大市"评级，目标价从50美元升至55美元；美银证券：维持Rocket Pharmaceuticals"买入"评级，目标价从8美元升至9美元
03-31 16:30
Growing pressures are reshaping the CPG landscape—Deutsche Bank
The long-standing assumption of consumer packaged goods (CPG) as a reliable defensive play for investors is being challenged by intensifying headwinds and changing dynamics, some of which are fleeting...
03-31 02:50
Deutsche Bank Maintains Buy on Monster Beverage, Lowers Price Target to $90
Deutsche Bank analyst Steve Powers maintains Monster Beverage (NASDAQ:MNST) with a Buy and lowers the price target from $94 to $90.
03-31 01:26
Nasdaq's oversold stocks amid scaling Middle East tensions: PEP, NXPI, KHC
Investor sentiment was majorly weighed down last week by escalating tensions over the U.S.-Iran conflict, which drove crude oil prices sharply higher and rekindled fears of a stagflationary environmen...
03-23 16:25
美股大行评级 | 能源股获大行青睐！美国铝业、康索尔能源、康菲石油、EOG能源等获上调目标价；多只航空股遭下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Altimmune"买入"评级，目标价从12美元升至25美元；BTIG：维持Jade Biosciences"买入"评级，目标价从28美元升至39美元
03-17 11:45
Wells Fargo Maintains Overweight on Monster Beverage, Lowers Price Target to $90
Wells Fargo analyst Chris Carey maintains Monster Beverage (NASDAQ:MNST) with a Overweight and lowers the price target from $94 to $90.
03-16 22:10
U.S. RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Cogent Biosciences, Summit Therapeutics
U.S. RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Cogent Biosciences, Summit Therapeutics March 16 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Alnylam Pharmaceuticals, Cogent Biosciences and Summit Therapeutics on Monday
03-16 18:00
Coca-Cola tops growth factor grades among S&P consumer staples holdings
The S&P 500 has experienced a challenging two-week period marked by escalating geopolitical tensions, sector rotation into defensives, and technical deterioration. In light of this, below is a list of...
03-13 21:49
怪物饮料股价单日下跌4.97%至81.06美元，Q4营收21.3亿美元
经济观察网 怪物饮料在2025财年第四季度财报中披露了积极的新品计划，但股价在2026年3月2日单日下跌4.97%，收盘于81.06美元。根据公开信息，下跌可能...
03-03 05:40
美股大行评级 | 下调居多！多邻国、Elastic、Flutter、欧特克、Zscaler等遭多家机构下调目标价
今日重点评级关注：巴克莱：维持C4 Therapeutics"超配"评级，目标价从5美元升至7美元；富国银行：维持Agilon Health"超配"评级，目标价从1美元升至1.5美元
03-02 14:08
